Chemoinformaics analysis of octadeca-2,9-dienoic-acid
| Molecular Weight | 480.378 | nRot | 4 |
| Heavy Atom Molecular Weight | 460.218 | nRig | 12 |
| Exact Molecular Weight | 480.09 | nRing | 4 |
| Solubility: LogS | -4.033 | nHRing | 2 |
| Solubility: LogP | 3.658 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 17 |
| nHA | 13 | APOL | 58.8319 |
| nHD | 9 | BPOL | 26.1401 |
| QED | 0.704 |
| Synth | 4.129 |
| Natural Product Likeliness | 2.912 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.516 |
| MDCK | 0.000013 |
| BBB | 0.864 |
| PPB | 0.903159 |
| VDSS | 2.719 |
| FU | 0.0325327 |
| CYP1A2-inh | 0.167 |
| CYP1A2-sub | 0.516 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.6 |
| CYP2c9-inh | 0.082 |
| CYP2c9-sub | 0.611 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.232 |
| CYP3a4-sub | 0.4 |
| CL | 11.09 |
| T12 | 0.205 |
| hERG | 0.027 |
| Ames | 0.013 |
| ROA | 0.018 |
| SkinSen | 0.071 |
| Carcinogencity | 0.729 |
| EI | 0.592 |
| Respiratory | 0.845 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.86646 |